RE:Paladin 2.0 Fastforward.....I would put Bioniche (BNC.T) in that mix as well, as they already have the leading candidate for Bladder Cancer that has already had a Phase 3 successful trial with about 25% efficiency and an extremely good tolerance rate.
It has Fast track Status in the USA, and they have made an application to the FDA. See: https://www.stockhouse.com/companies/news/t.bnc/bioniche-life-sciences-inc
However, Paladin/Endo already has the rights to this Drug in Canada, South Africa and I think Brazil? So it is possible Paladin/Endo will want the rest as well.